Clinical Trials Browser

Phase NA × OTHER × cediranib × Clear all

NCT02681237 2022-05-09

A Study of Cediranib and Olaparib at Disease Worsening in Ovarian Cancer

Phase NA Completed

Ovarian Neoplasms